Boundless Bio, Inc.
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.89M | -13.88M | -15.68M | -15.76M | -16.45M |
| Total Depreciation and Amortization | 307.00K | 310.00K | 317.00K | 317.00K | 296.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.64M | 1.53M | 1.82M | 1.84M | 1.72M |
| Change in Net Operating Assets | 831.00K | 1.85M | 1.71M | -927.00K | -1.13M |
| Cash from Operations | -10.11M | -10.20M | -11.83M | -14.53M | -15.56M |
| Capital Expenditure | -424.00K | -15.00K | -48.00K | -59.00K | -466.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.40M | 10.49M | 11.34M | 3.12M | 2.29M |
| Cash from Investing | 12.97M | 10.48M | 11.29M | 3.06M | 1.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.00K | 0.00 | 117.00K | -- | 113.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 24.00K | 0.00 | 117.00K | -- | 113.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.89M | 283.00K | -420.00K | -11.47M | -13.63M |